Repurposing FDA-Approved Agents to Develop a Prototype Helicobacter pylori Shikimate Kinase (HPSK) Inhibitor: A Computational Approach Using Virtual Screening, MM-GBSA Calculations, MD Simulations, and DFT Analysis
- Abdulaziz H. Al Khzem*
- , Tagyedeen H. Shoaib
- , Rua M. Mukhtar
- , Mansour S. Alturki*
- , Mohamed S. Gomaa
- , Dania Hussein
- , Nada Tawfeeq
- , Mohsina Bano
- , Mohammad Sarafroz
- , Raghad Alzahrani
- , Hanin Alghamdi
- , Thankhoe A. Rants’o
*Corresponding author for this work
- Imam Abdulrahman Bin Faisal University
- University of Gezira
- University of Utah
Research output: Contribution to journal › Article › peer-review
10
Link opens in a new tab
Scopus
citations